138 related articles for article (PubMed ID: 24307221)
1. Comparative short-term effect of once-daily molsidomine on chronic angina in general practitioners' versus cardiologists' coronary patient populations.
Messin R
Adv Ther; 2014 Jan; 31(1):91-106. PubMed ID: 24307221
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities.
Messin R; Dubois C; Famaey JP
Adv Ther; 2008 Nov; 25(11):1200-14. PubMed ID: 19002405
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: double-blind and open-label studies.
Messin R; Cerreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
Adv Ther; 2006; 23(1):107-30. PubMed ID: 16644612
[TBL] [Abstract][Full Text] [Related]
4. Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina.
Messin R; Bruhwyler J; Dubois C; Famaey JP; Géczy J
Adv Ther; 2006; 23(4):601-14. PubMed ID: 17050502
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina.
Van Hove C; Carreer-Bruhwyler F; Géczy J; Herman AG
Atherosclerosis; 2005 Jun; 180(2):399-405. PubMed ID: 15910868
[TBL] [Abstract][Full Text] [Related]
7. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
Witchitz S; Kolsky H; Moisson P; Valette H
Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial.
Messin R; Karpov Y; Baikova N; Bruhwyler J; Monseu MJ; Guns C; Géczy J
J Cardiovasc Pharmacol; 1998 Feb; 31(2):271-6. PubMed ID: 9475269
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
10. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
Ciopor M; Fischer A; Turina J; Hess OM
Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial.
Barbato E; Herman A; Benit E; Janssens L; Lalmand J; Hoffer E; Chenu P; Guédès A; Missault L; Pirenne B; Cardinal F; Vercauteren S; Wijns W
Atherosclerosis; 2015 Jun; 240(2):351-4. PubMed ID: 25875387
[TBL] [Abstract][Full Text] [Related]
12. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.
Rothberg MB; Sivalingam SK; Ashraf J; Visintainer P; Joelson J; Kleppel R; Vallurupalli N; Schweiger MJ
Ann Intern Med; 2010 Sep; 153(5):307-13. PubMed ID: 20820040
[TBL] [Abstract][Full Text] [Related]
13. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
[TBL] [Abstract][Full Text] [Related]
14. Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study.
Rossignol P; Hosseini K; Tropeano AI; Fay R; Tsatsaris A; Guillemin F; Mounier-Vehier C
J Hypertens; 2013 Jan; 31(1):177-85. PubMed ID: 23111625
[TBL] [Abstract][Full Text] [Related]
15. [Long-term antihypertensive effect of delayed-action molsidomine].
Fach WA; Kostanecka T; Kober G
Z Kardiol; 1994 Sep; 83(9):646-51. PubMed ID: 7801667
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical profile and management of outpatients with heart failure with reduced left ventricular ejection fraction treated by general practitioners and cardiologists in contemporary Poland: the results from the DATA-HELP registry.
Jankowska EA; Kalicinska E; Drozd M; Kurian B; Banasiak W; Ponikowski P
Int J Cardiol; 2014 Oct; 176(3):852-8. PubMed ID: 25156847
[TBL] [Abstract][Full Text] [Related]
17. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice.
Glezer MG; Vygodin VA;
Adv Ther; 2018 Sep; 35(9):1368-1377. PubMed ID: 30105656
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and management of uncontrolled hypertension in French patients aged over 80 years.
Ragot S; Sosner P; Dievart F; Herpin D
Arch Cardiovasc Dis; 2014 Apr; 107(4):236-44. PubMed ID: 24767820
[TBL] [Abstract][Full Text] [Related]
19. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
